Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamaguchi, N
Right arrow Articles by Stafford, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamaguchi, N
Right arrow Articles by Stafford, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The role of amino-terminal residues of the heavy chain of factor IXa in the binding of its cofactor, factor VIIIa

N Hamaguchi, SP Bajaj, KJ Smith and DW Stafford

Department of Biochemistry, Duke University Medical Center, Durham, NC.

The purpose of this study is to determine which residues of the factor IXa heavy chain are important for interaction with the cofactor of factor IXa, factor VIIIa. Because the monoclonal antibody (MoAb) FXC008 inhibits interaction between factors IXa and VIIIa, and because it also reacts with residues 181-310 of the factor IXa heavy chain, we used the computer-modelled structure of the factor IXa heavy chain to select charged surface residues likely to interact with FXC008 and/or factor VIIIa. We made mutations in the region of residues 181-310 of the heavy chain of factor IX, and replaced these amino acids individually with those located at the same position in factor X. The mutated factor IX retained complete clotting activity and thus interacted normally with factor VIIIa. Five mutant proteins (factor IXK214F, factor IXK228R, factor IXE240Q, factor IXK247V, and factor IXN260K) reacted with heavy chain-specific MoAbs FXC008 and A-5. Neither factor IXD276K nor factor IXR248H bound to FXC008. Factor IXR252V had reduced affinity to FXC008. Our results suggest the following: (1) factor IXa residues 214, 228, 240, 247, 248, 252, 260, and 276 are not involved in specific interaction with factor VIIIa; and (2) the FXC008 and factor VIIIa binding sites may not share critical residues.

Volume 84, Issue 6, pp. 1837-1842, 09/15/1994
Copyright © 1994 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Yang, Y.-J. Chang, S.-W. Lin, and P. N. Walsh
Identification of Residues Asn89, Ile90, and Val107 of the Factor IXa Second Epidermal Growth Factor Domain That Are Essential for the Assembly of the Factor X-activating Complex on Activated Platelets
J. Biol. Chem., November 5, 2004; 279(45): 46400 - 46405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-J. Chang, H.-L. Wu, N. Hamaguchi, Y.-C. Hsu, and S.-W. Lin
Identification of Functionally Important Residues of the Epidermal Growth Factor-2 Domain of Factor IX by Alanine-scanning Mutagenesis. RESIDUES ASN89-GLY93 ARE CRITICAL FOR BINDING FACTOR VIIIa
J. Biol. Chem., July 5, 2002; 277(28): 25393 - 25399.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D J Bowen
Haemophilia A and haemophilia B: molecular insights
Mol. Pathol., April 1, 2002; 55(2): 127 - 144.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D J Bowen
Haemophilia A and haemophilia B: molecular insights
Mol. Pathol., February 1, 2002; 55(1): 1 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mathur and S. P. Bajaj
Protease and EGF1 Domains of Factor IXa Play Distinct Roles in Binding to Factor VIIIa. IMPORTANCE OF HELIX 330 (HELIX 162 IN CHYMOTRYPSIN) OF PROTEASE DOMAIN OF FACTOR IXa IN ITS INTERACTION WITH FACTOR VIIIa
J. Biol. Chem., June 25, 1999; 274(26): 18477 - 18486.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Lenting, J. A. van Mourik, and K. Mertens
The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
Blood, December 1, 1998; 92(11): 3983 - 3996.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mathur, D. Zhong, A. K. Sabharwal, K. J. Smith, and S. P. Bajaj
Interaction of Factor IXa with Factor VIIIa. EFFECTS OF PROTEASE DOMAIN Ca2+ BINDING SITE, PROTEOLYSIS IN THE AUTOLYSIS LOOP, PHOSPHOLIPID, AND FACTOR X
J. Biol. Chem., September 12, 1997; 272(37): 23418 - 23426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. O'Brien, L. V. Medved, and P. J. Fay
Localization of Factor IXa and Factor VIIIa Interactive Sites
J. Biol. Chem., November 10, 1995; 270(45): 27087 - 27092.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1994 by American Society of Hematology         Online ISSN: 1528-0020